Impact of Meal Fatty Acids on Postprandial Vascular Reactivity (DIVAS-2)

December 2, 2015 updated by: Julie Lovegrove, University of Reading

The Acute Effects of Meals Rich in Saturated, Monounsaturated and n-6 Polyunsaturated Fatty Acids on Vascular Function

Cardiovascular disease (CVD) is the leading cause of death in women. Premenopausal women have a lower risk of CVD compared with men of a similar age. However, the incidence of CVD increases greatly after the menopause. The risk of heart disease is strongly associated with the health of an individual's blood vessels. It is thought that changes to the type of fat the investigators eat in their diet may affect the normal functioning and elasticity of the blood vessels, as well as affect cholesterol levels in the blood. Types of fat in the diet include monounsaturated fats (found mainly in olive oil), n-6 polyunsaturated fats (found mainly in sunflower oil) and saturated fats (found mainly in dairy products, such as butter and cheese). Since the investigators are in the fed (or postprandial) state for up to 18 hours of the day, it is important to see how these different fats affect the investigators blood vessels and blood fats over the course of the day after eating a meal. The aim of this study is to determine how consuming meals rich in saturated fats, n-6 polyunsaturated fats or monounsaturated fats influence the normal functioning and elasticity of the blood vessels throughout the day in postmenopausal women. A secondary aim is to determine the effects of these different dietary fats on a range of accepted heart disease risk markers including circulating levels of fats (lipids) and glucose in the blood.

Study Overview

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Berkshire
      • Reading, Berkshire, United Kingdom, RG6 6AP
        • University of Reading

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Postmenopausal (not menstruated for at least 1 year)
  • Plasma triacylglycerol (TAG) between 0.8 and 4.0 mmol/l
  • Body mass index (BMI) between 18-35 kg/m2
  • Total cholesterol (TC): <8 mmol/l
  • Systolic blood pressure <160 mmHg and diastolic blood pressure <100 mmHg
  • Non-smoker

Exclusion Criteria:

  • Having suffered a myocardial infarction/stroke in the past 12 months
  • Diabetic (diagnosed as fasting blood glucose >7 mmol/l) or suffering from other endocrine disorders
  • Suffering from renal or bowel disease or have a history of cholestatic liver or pancreatitis
  • On drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
  • History of alcohol abuse
  • On hormone replacement therapy (HRT)
  • Planning or on a weight reducing regime
  • Taking nutritional supplements (e.g. fish oil, calcium)
  • Anaemic: haemoglobin <11.5 g/dl

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Meal rich in saturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in saturated fats
Other Names:
  • SFA
Experimental: Meal rich in monounsaturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in monounsaturated fats
Other Names:
  • MUFA
Experimental: Meal rich in n-6 polyunsaturated fats
Subjects are asked to consume a breakfast (0 min) and lunch (330 min) rich in n-6 polyunsaturated fats
Other Names:
  • n-6 PUFA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change from baseline in vascular reactivity measured by flow-mediated dilatation (FMD)
Time Frame: Acute study: measured at 0 (baseline), 180, 300 and 420 min
Acute study: measured at 0 (baseline), 180, 300 and 420 min

Secondary Outcome Measures

Outcome Measure
Time Frame
Change from baseline in vascular reactivity measured by laser Doppler imaging with iontophoresis of acetylcholine (endothelium-dependent) and sodium nitroprusside (endothelium-independent)
Time Frame: Acute study: measured at 0 (baseline), 240 and 450 min
Acute study: measured at 0 (baseline), 240 and 450 min
Change from baseline in plasma lipids (primarily triacylglycerol, apolipoprotein B and non-esterified fatty acids)
Time Frame: Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
Change from baseline in arterial stiffness measured by digital volume pulse (stiffness index and reflection index)
Time Frame: Acute study: taken at 0 (baseline), 240 amd 450 min
Acute study: taken at 0 (baseline), 240 amd 450 min
Change from baseline in blood pressure (systolic blood pressure, diastolic blood pressure and pulse pressure)
Time Frame: Acute study: taken at 0 (baseline), 240 and 450 min
Acute study: taken at 0 (baseline), 240 and 450 min
Change from baseline in markers of insulin resistance (glucose, insulin, indices of insulin resistance/sensitivity)
Time Frame: Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
Acute study: taken at 30 min intervals between 0 min (baseline) and 480 min
Change from baseline in nitric oxide (total plasma nitrates and nitrites)
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
Acute study: 0 (baseline), 180, 300 and 420 min
Change from baseline in plasma markers of endothelial activation (e.g. E-selectin, P-selectin, vascular cell adhesion molecule (VCAM-1))
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
Acute study: 0 (baseline), 180, 300 and 420 min
Change from baseline in plasma phospholipid fatty acid composition
Time Frame: Acute study: 0 (baseline), 180, 300 and 420 min
Acute study: 0 (baseline), 180, 300 and 420 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

May 15, 2014

First Submitted That Met QC Criteria

May 21, 2014

First Posted (Estimate)

May 22, 2014

Study Record Updates

Last Update Posted (Estimate)

December 3, 2015

Last Update Submitted That Met QC Criteria

December 2, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on Saturated fat

3
Subscribe